Cas:63969-05-1 3-Amino-N-(3-Chloro-2-methylphenyl)-4-methoxybenzamide manufacturer & supplier

We serve Chemical Name:3-Amino-N-(3-Chloro-2-methylphenyl)-4-methoxybenzamide CAS:63969-05-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Amino-N-(3-Chloro-2-methylphenyl)-4-methoxybenzamide

Chemical Name:3-Amino-N-(3-Chloro-2-methylphenyl)-4-methoxybenzamide
CAS.NO:63969-05-1
Synonyms:3-amino-N-(3-chloro-2-methylphenyl)-4-methoxybenzamide
Molecular Formula:C15H15ClN2O2
Molecular Weight:290.74500
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.304
Index of Refraction:
PSA:64.35000
Exact Mass:290.08200
LogP:4.14570

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-amino-N-(3-chloro-2-methylphenyl)-4-methoxybenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-amino-N-(3-chloro-2-methylphenyl)-4-methoxybenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-amino-N-(3-chloro-2-methylphenyl)-4-methoxybenzamide Use and application,3-amino-N-(3-chloro-2-methylphenyl)-4-methoxybenzamide technical grade,usp/ep/jp grade.


Related News: Flexibility in a CDMO is the key to ensure speed of tech-transfer which is a true litmus test for CDMOs which can help a company chose between competing analytical strategies, manufacturing technology and knowledge for improving productivity. 2,4,5-Trimethoxy-propiophenon-(2,4-dinitro-phenylhydrazon) manufacturers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, (1R,3R,6S,7S,9R)-9-Bromo-4-oxa-tricyclo[4.2.1.03,7]nonan-5-one suppliers When these modified cells are given back to the patient, they are transported in the bloodstream to the bone marrow where they start to make healthy red blood cells that produce beta-globin. The effects of Zynteglo are expected to last for the patient’s lifetime. 7-Chloro-2-methyl-1′-[5,5-bis(4-fluorophenyl)pentyl]-spiro[2H-1,4-benzodioxepin-3(5H)4′-piperidine]hydrochloride vendor & factory.